Intercept Pharmaceuticals, Inc. (ICPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.69 |
| Open | 13.52 |
| Bid | 13.42 x 800 |
| Ask | 13.45 x 800 |
| Day's range | 13.11 - 13.65 |
| 52-week range | 10.81 - 21.86 |
| Volume | |
| Avg. volume | 785,298 |
| Market cap | 560.88M |
| Beta (5Y monthly) | 1.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.56 |
| Earnings date | 04 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 23.79 |
- Zacks
Intercept (ICPT) Stock Down on FDA Committee Update on NDA
Intercept (ICPT) declines on news of a GIDAC meeting to discuss the NDA for the OCA for NASH in May.
- Simply Wall St.
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) down to US$672m market cap, but institutional owners may not be as affected after a year of 8.0% returns
Key Insights Institutions' substantial holdings in Intercept Pharmaceuticals implies that they have significant...
- Zacks
Heres Why Intercept (ICPT) Stock is Up 28.7% in 3 Months
Intercept (ICPT) gains 28.7% in the past 3 months on NDA's acceptance for NASH treatment and Ocaliva's performance.
© 2023 Yahoo. All rights reserved.
